We found 117 records for "Legal"

Articles

How multinational pharmaceutical companies deal with bribery and corruption risks in China

25th June 2014

 How multinational pharmaceutical companies deal with bribery and corruption risks in ChinaArticles

Recent investigations by Chinese authorities into bribery and corruption allegations in multinational pharmaceutical companies in China show an increased commitment to crack down on corruption.Since 2009, China has accelerated its...

Read more

The trend to blend: M&A in pharma - Are you ready?

17th June 2014

 The trend to blend: M&A in pharma - Are you ready?Articles

Paul Gershlick and Laura Barrell examine the recent surge in mergers and acquisitions, and look at what small to medium sized firms can do to make themselves more attractive to...

Read more

TTIP matters for patients and the global economy alike

29th April 2014

 TTIP matters for patients and the global economy alikeArticles

Andrew Hotchkiss, President of Europe, Canada & Australia at Eli Lilly and Company, explores how the Transatlantic Trade and Investment Partnership (TTIP) can benefit the patients of tomorrow.Albert Einstein, one...

Read more

Pharma products, patents & problems – the Unified Patent Court: plan your patent strategy

24th April 2014

 Pharma products, patents & problems – the Unified Patent Court: plan your patent strategyArticles

As we see the patent system in Europe undergo its biggest overhaul in decades, we explore the new Unified Patent Court Agreement and how it will impact on your patent...

Read more

News

AbbVie hits out at US Treasury as Shire bid dies

21st October 2014

 AbbVie hits out at US Treasury as Shire bid dies News

Following AbbVie's recommendation to its shareholders to vote against the takeover of Shire last week, Shire's board has agreed to terminate the Cooperation Agreement and release AbbVie from its obligations...

Read more

AbbVie withdraws Shire bid following US tax changes

16th October 2014

 AbbVie withdraws Shire bid following US tax changesNews

AbbVie's board has recommended its stockholders vote against its proposed £31 billion buyout of Shire as a result of the tightening of US tax laws in September to deter so-called...

Read more

Merck to face sex discrimination charges in US

10th October 2014

 Merck to face sex discrimination charges in USNews

Five women who claim they suffered sex discrimination while working as sales reps for Merck have been told that the company's motion to dismiss the case has been denied by...

Read more

GSK China guilty of bribery

19th September 2014

 GSK China guilty of briberyNews

The Changsha Intermediate People's Court in Hunan Province, China, has ruled that GlaxoSmithKline China Investment Co. Ltd (GSKCI) has, according to Chinese law, offered money or property to non-government personnel...

Read more

Events

Big Data & Analytics for Pharma Summit

5th November 2014 - 6th November 2014

Big Data & Analytics for Pharma Summit

The Big Data & Analytics for Pharma Summit returns to Philadelphia on November 5 & 6, boasting a lineup of the most influential pharmaceutical executives driving big data initiatives in...

Read more

Life Sciences IP Summit 2014

12th November 2014 - 14th November 2014

Life Sciences IP Summit 2014

An innovative new solution written in response to market demand, The Life Sciences IP Summit is a culmination of C5’s industry-leading portfolio of intellectual property events for the life sciences...

Read more

Asia Clinical Trials Leaders Summit 2014

19th November 2014 - 20th November 2014

Asia Clinical Trials Leaders Summit 2014

Asia Clinical Trials Leaders Summit 2014 About ACTLS 2014 Over the years, Asia has increasingly become the hotbed and destination for the clinical research. From one side, increasingly global pharmaceutical companies have...

Read more

Changing provider landscape: taking the Dalton Review forward

25th November 2014

Changing provider landscape: taking the Dalton Review forward

In October, Sir David Dalton will launch his review, offering evidence for NHS providers on developing different organisational models to tackle increasing strategic and financial challenges, and improve patient care....

Read more